Strategies to minimize placebo effects in research investigations

Filipe B Rodrigues1, Joaquim J Ferreira2

  • 1UCL Huntington's Disease Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom; Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; Instituto de Medicina Molecular, Lisbon, Portugal.

Insights

Placebo-controlled trials are essential for new treatments but can be complicated by placebo effects. Strategies exist to manage these challenges in clinical trial design, conduct, and analysis.

Area of Science:

  • Clinical Trials
  • Pharmacology
  • Medical Research Methodology

Background:

  • Placebo-controlled trials are the gold standard for evaluating new interventions when no standard of care exists.
  • These trials help reduce performance and detection bias by providing a direct comparison to the intervention.
  • However, placebo arms introduce unique challenges in clinical trial design, conduct, and analysis.

Purpose of the Study:

  • To contextualize the challenges posed by placebo effects in clinical trials.
  • To discuss potential strategies for mitigating the confounding effects of placebo.
  • To explore future directions in managing placebo effects in research.

Main Methods:

  • Discussion of challenges in clinical trial design, conduct, and analysis related to placebo effects.
  • Exploration of strategies to mitigate confounding placebo effects.
  • Review of specific clinical trial designs and their relevance to placebo mitigation.

Main Results:

  • Placebo effects can complicate trials, especially with non-additive effects, outcome ceiling/floor effects, or large predicted intervention effects.
  • Various strategies can be employed to address these challenges, tailored to specific trial designs.
  • The chapter provides an overview of current issues and potential solutions.

Conclusions:

  • Understanding and managing placebo effects is crucial for the integrity of clinical trial results.
  • Adaptable strategies are necessary to overcome the complexities introduced by placebo arms.
  • Continued research and methodological innovation are needed to optimize placebo-controlled trial designs.

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.7K
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.7K
The Placebo Effect01:54

The Placebo Effect

The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
319
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
109
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
8.7K